Skip to content

Stereotaxis STXS Unrecognized Tax Benefits

Unrecognized Tax Benefits at other companies

ITG
Integer HoldingsITGR
$2.9M-27.5%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$2.32M+11.1%
NVE Corporation logo
NVE CorporationNVEC
$0
AngioDynamics logo
AngioDynamicsANGO
$4.07M-16.1%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Stereotaxis’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's unrecognized tax benefits?
Stereotaxis (STXS) reported unrecognized tax benefits of $100K in Q4 2025.
What does unrecognized tax benefits mean?
This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.